(Q35053940)

6 August 2017

1 reference

title

Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma (English)

1 reference

6 August 2017

0 references

Matthew R Smith

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

97

1 reference

6 August 2017

issue

3 Suppl

1 reference

6 August 2017

page(s)

789-795

1 reference

The structural basis of bone fragility in men.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

The predictive value of forearm bone mineral content measurements in men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Cross-sectional assessment of age-related bone loss in men: the MINOS study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Comparative tolerability of drug therapies for hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

The diagnostic value of bone scintigraphy in patients with low back pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11149

1 reference

7 January 2021

How is androgen-dependent metastatic prostate cancer best treated?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Estrogens in the Treatment of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Low bone mineral density in hormone-naïve men with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Frailty in older adults: evidence for a phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Alendronate for the Treatment of Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11149

7 January 2021

Identifiers

DOI

10.1002/CNCR.11149

1 reference

6 August 2017

1 reference